Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

344 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bacillus Calmette-Guérin vaccination for protection against recurrent herpes labialis: a nested randomised controlled trial.
Pittet LF, Moore CL, McDonald E, Barry S, Bonten M, Campbell J, Croda J, Dalcolmo M, Davidson A, Douglas MW, Gardiner K, Gwee A, Jardim B, Lacerda MVG, Lucas M, Lynn DJ, Manning L, de Oliveira RD, Perrett KP, Prat-Aymerich C, Richmond PC, Rocha JL, Rodriguez-Baño J, Warris A, Wood NJ, Messina NL, Curtis N; BRACE Trial Consortium Group. Pittet LF, et al. Among authors: lacerda mvg. EClinicalMedicine. 2023 Sep 11;64:102203. doi: 10.1016/j.eclinm.2023.102203. eCollection 2023 Oct. EClinicalMedicine. 2023. PMID: 37719417 Free PMC article.
Specific and off-target immune responses following COVID-19 vaccination with ChAdOx1-S and BNT162b2 vaccines-an exploratory sub-study of the BRACE trial.
Messina NL, Germano S, McElroy R, Bonnici R, Grubor-Bauk B, Lynn DJ, McDonald E, Nicholson S, Perrett KP, Pittet LF, Rudraraju R, Stevens NE, Subbarao K, Curtis N; BRACE trial. Messina NL, et al. EBioMedicine. 2024 May;103:105100. doi: 10.1016/j.ebiom.2024.105100. Epub 2024 Apr 24. EBioMedicine. 2024. PMID: 38663355 Free PMC article.
Bacille Calmette-Guérin vaccination to prevent febrile and respiratory illness in adults (BRACE): secondary outcomes of a randomised controlled phase 3 trial.
Pittet LF, Messina NL, McDonald E, Orsini F, Barry S, Bonten M, Campbell J, Croda J, Croda MG, Dalcolmo M, Gardiner K, Gwee A, Jardim B, Lacerda MVG, Lucas M, Lynn DJ, Manning L, Perrett KP, Post JJ, Prat-Aymerich C, Richmond PC, Rocha JL, Rodriguez-Baño J, Warris A, Wood NJ, Davidson A, Curtis N; BRACE Trial Consortium Group. Pittet LF, et al. Among authors: lacerda mvg. EClinicalMedicine. 2024 May 13;72:102616. doi: 10.1016/j.eclinm.2024.102616. eCollection 2024 Jun. EClinicalMedicine. 2024. PMID: 38774675 Free PMC article.
BCG vaccination of healthcare workers for protection against COVID-19: 12-month outcomes from an international randomised controlled trial.
Messina NL, Pittet LF, McDonald E, Moore C, Barry S, Bonten M, Byrne A, Campbell J, Croda J, Croda MG, Dalcolmo M, de Almeida E Val FF, de Oliveira RD, Dos Santos G, Douglas MW, Gardiner K, Gwee A, Jardim BA, Kollmann T, Lacerda MV, Lucas M, Lynn DJ, Manning L, Marshall H, O'Connell A, Perrett KP, Post JJ, Prat-Aymerich C, Rocha JL, Rodriguez-Baño J, Wadia U, Warris A, Davidson A, Curtis N; BRACE Trial Consortium Group. Messina NL, et al. J Infect. 2024 Oct;89(4):106245. doi: 10.1016/j.jinf.2024.106245. Epub 2024 Aug 8. J Infect. 2024. PMID: 39127450 Free PMC article. Clinical Trial.
Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial.
Yuen MF, Asselah T, Jacobson IM, Brunetto MR, Janssen HLA, Takehara T, Hou JL, Kakuda TN, Lambrecht T, Beumont M, Kalmeijer R, Guinard-Azadian C, Mayer C, Jezorwski J, Verbinnen T, Lenz O, Shukla U, Biermer M; REEF-1 Study Group. Yuen MF, et al. Lancet Gastroenterol Hepatol. 2023 Sep;8(9):790-802. doi: 10.1016/S2468-1253(23)00148-6. Epub 2023 Jul 10. Lancet Gastroenterol Hepatol. 2023. PMID: 37442152 Clinical Trial.
Assessing tafenoquine implementation in Brazil: a qualitative evaluation of perceptions of healthcare providers and Plasmodium vivax patients (QualiTRuST Study).
Santos APC, Brito MAM, Oliveira APS, Dávila RN, Gama HSS, Silva EART, Amazonas HA Jr, Balieiro PCS, Rufatto R, Grewal Daumerie P, Peterka CRL, Batista Pereira D, Lacerda MVG, Murta FLG. Santos APC, et al. Among authors: lacerda mvg. Malar J. 2024 Dec 23;23(1):399. doi: 10.1186/s12936-024-05209-1. Malar J. 2024. PMID: 39716245 Free PMC article.
Spatially resolved single-cell atlas unveils a distinct cellular signature of fatal lung COVID-19 in a Malawian population.
Nyirenda J, Hardy OM, Silva Filho JD, Herder V, Attipa C, Ndovi C, Siwombo M, Namalima TR, Suwedi L, Ilia G, Nyasulu W, Ngulube T, Nyirenda D, Mvaya L, Phiri J, Chasweka D, Eneya C, Makwinja C, Phiri C, Ziwoya F, Tembo A, Makwangwala K, Khoswe S, Banda P, Morton B, Hilton O, Lawrence S, Dos Reis MF, Melo GC, de Lacerda MVG, Trindade Maranhão Costa F, Monteiro WM, Ferreira LCL, Johnson C, McGuinness D, Jambo K, Haley M, Kumwenda B, Palmarini M, Denno DM, Voskuijl W, Kamiza SB, Barnes KG, Couper K, Marti M, Otto TD, Moxon CA. Nyirenda J, et al. Among authors: de lacerda mvg. Nat Med. 2024 Dec;30(12):3765-3777. doi: 10.1038/s41591-024-03354-3. Epub 2024 Nov 20. Nat Med. 2024. PMID: 39567718 Free PMC article.
Relative efficacy of anti-Plasmodium vivax malaria combination drugs in preventing transmission to two major Anopheles mosquitoes in the first few days of treatment.
Martinez EG, Alencar RM, Santana RAG, Barbosa LRA, Almeida ACG, Mwangi VI, Rocha SRDN, de Souza LEB, Silva LM, Pinilla YT, Becker N, Monteiro WM, de Lacerda MVG, Secundino TS, Godoy RSM, Rodrigues NB, Secundino NFC, de Melo GC, Pimenta PFP. Martinez EG, et al. Among authors: de lacerda mvg. Int J Infect Dis. 2025 Jan;150:107297. doi: 10.1016/j.ijid.2024.107297. Epub 2024 Nov 12. Int J Infect Dis. 2025. PMID: 39537096 Free article.
Primaquine for uncomplicated Plasmodium vivax malaria in children younger than 15 years: a systematic review and individual patient data meta-analysis.
Commons RJ, Rajasekhar M, Allen EN, Yilma D, Chotsiri P, Abreha T, Adam I, Awab GR, Barber BE, Brasil LW, Chu CS, Cui L, Edler P, Gomes MDSM, Gonzalez-Ceron L, Grigg MJ, Hamid MMA, Hwang J, Karunajeewa H, Lacerda MVG, Ladeia-Andrade S, Leslie T, Longley RJ, Monteiro WM, Pasaribu AP, Poespoprodjo JR, Richmond CL, Rijal KR, Taylor WRJ, Thanh PV, Thriemer K, Vieira JLF, White NJ, Zuluaga-Idarraga LM, Workman LJ, Tarning J, Stepniewska K, Guerin PJ, Simpson JA, Barnes KI, Price RN; WorldWide Antimalarial Resistance Network Paediatric Primaquine Vivax Study Group. Commons RJ, et al. Among authors: lacerda mvg. Lancet Child Adolesc Health. 2024 Nov;8(11):798-808. doi: 10.1016/S2352-4642(24)00210-4. Epub 2024 Sep 24. Lancet Child Adolesc Health. 2024. PMID: 39332427 Free PMC article.
Perception and barriers to access Pre-exposure Prophylaxis for HIV/AIDS (PrEP) among the MSM (men who have sex with men) Brazilian Amazon: A qualitative study.
Batista DR, Dávila RN, Santos ACD, Rocha FQ, Araújo JA, Alencar AC, Nascimento LR, Araújo ND, Lopes SCP, Araújo PS, Filgueiras RA, Saraiva PF, Lacerda MVG, Baía-da-Silva DC, Murta FLG. Batista DR, et al. Among authors: lacerda mvg. PLoS One. 2024 Sep 26;19(9):e0296201. doi: 10.1371/journal.pone.0296201. eCollection 2024. PLoS One. 2024. PMID: 39325811 Free PMC article.
344 results